As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...

President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...

Botox and the GLP-1 drug Trulicity are among the latest group of prescription drugs subject to price controls by Medicare. The Centers for Medicare & Medicaid Services (CMS), the federal agency that ...

Hello and welcome to Health Affairs This Week. I'm your host, Jeff Byers. We are recording on 11/04/2025. In late September, CMS published its final guidance for the third cycle of the Medicare drug ...

“While we support affordable health care, the price controls that we are challenging would reduce access to new medicines that Americans are counting on, and would set a devastating precedent for all ...

“[T]he Third Circuit found that CMS’ treatment of six [Novo Nordisk] products as a single drug was ultimately precluded by the IRA’s bar against judicial review.” Yesterday, the U.S. Court of Appeals ...